Exception from Informed Consent in Emergency Research: What EFIC Is and How It Works
Clinical trials save lives, but they usually start with a consent form. In an emergency, there is no time for that. A patient in cardiac arrest cannot read a form. A person with a severe head injury cannot ask questions. If research only happened with prior consent, emergency medicine would never improve. That is the gap the exception from informed consent, known as EFIC, was built to fill.
EFIC lets researchers enroll patients in certain emergency studies without their prior informed consent. It is a narrow exception, not a general waiver. The Clarity Clinical Solutions video on EFIC walks through what it is, when it applies, and the safeguards that surround it. The short version: EFIC exists because some questions about life-threatening emergencies can only be answered in the moment, when consent is impossible.
When EFIC applies
The bar for using EFIC is high. The patient must be in a life-threatening situation. Getting informed consent must not be feasible, which usually means the patient is unconscious, incapacitated, or otherwise unable to consent in time. And the experimental intervention must offer the prospect of direct benefit to the patient, not just knowledge for science.
Common scenarios include cardiac arrest, severe traumatic injury, acute stroke, and other time-sensitive emergencies. In each case, the treatment window is measured in minutes. Waiting for consent would mean missing the window entirely. There must also be no equally effective alternative therapy available. The video makes a useful distinction: EFIC is not a waiver of consent. It is a carefully managed delay. Consent is obtained as soon as possible after enrollment, from the patient if they recover or from a legally authorized representative.
How we got here
EFIC did not appear out of nowhere. It sits on a history of hard lessons. The thalidomide disaster of the 1950s and 1960s, which caused severe birth defects in thousands of infants, led to the Kefauver-Harris Amendments of 1962 and a firm requirement for informed consent. The Belmont Report of 1979 then laid out the three principles that still anchor research ethics: respect for persons, beneficence, and justice. Those principles are the foundation the EFIC regulations were later built on, as the video explains.
The rules: 21 CFR 50.24
The regulatory home of EFIC is Section 50.24 of Title 21 of the Code of Federal Regulations (21 CFR 50.24). The FDA finalized the rule in 1996 after lengthy public deliberation. It sets out eight specific conditions an emergency research study must meet. Among them: the condition must be life-threatening, the patient must be unable to give consent, the intervention must offer the prospect of direct benefit, community consultation must happen before the study starts, public disclosure must occur, and there must be independent oversight of the data.
Institutional review boards carry the primary responsibility for reviewing and approving EFIC protocols. The FDA's guidance for IRBs, investigators, and sponsors explains how the agency expects these requirements to be applied in practice (FDA guidance: Exception from Informed Consent Requirements for Emergency Research).
Community consultation and public disclosure
The two most distinctive safeguards are community consultation and public disclosure. Before a study starts, researchers must go into the communities where the study will run. Town hall meetings, surveys, focus groups, and public advertising all count. The goal is to tell people what the study involves, what the risks are, and why it matters, and to listen to what they say in return. This is how the research earns a kind of collective consent even when individual consent is impossible.
Public disclosure continues after the study. Researchers must share results with the community when the trial concludes. The video describes disclosure methods that range from news media and community newsletters to websites and public meetings. This transparency gives communities a way to hold researchers accountable, and it shifts EFIC from a regulatory exception into a partnership between science and the people it serves.
Safety oversight inside the trial
EFIC studies also carry extra layers of safety monitoring. An independent data monitoring committee reviews accumulating data for safety concerns. The protocol must spell out how the team will contact legally authorized representatives. Patients can withdraw at any time, and their care is not affected if they do. The video notes that many patients and family members support EFIC once they understand these safeguards.
The record so far includes important wins for emergency medicine. In trauma, the POLAR trial studied hypothermia after traumatic brain injury. In stroke, the MR CLEAN trial investigated intra-arterial thrombectomy. In cardiac arrest, the Resuscitation Outcomes Consortium network ran multiple trials of advanced life support interventions. None of these would have been feasible with a traditional consent model, and all are cited in the video as examples of EFIC's value.
The debate
EFIC is not without critics, and the video does not hide that. Some argue it undermines patient autonomy even with community consultation. Others worry that vulnerable people, such as homeless individuals or non-English speakers, could be enrolled disproportionately. There is a real concern that the urgency of research could overshadow individual rights. Supporters answer that the safeguards, particularly IRB oversight and independent data monitoring, provide robust protection while letting critical research move forward.
Both sides of the argument are worth taking seriously. The studies show that many patients and families support EFIC when they understand the protections, and community consultation actively seeks input from survivors and their families. The dialogue is ongoing, and that is healthy.
The bottom line
EFIC is a vital tool for emergency research, and it is tightly regulated for good reason. It rests on ethical principles, historical lessons, and a federal rule with eight hard requirements. Community consultation, public disclosure, and independent oversight keep the balance between advancing medicine and protecting patients. It is not a loophole. It is a carefully designed exception for situations where the alternative is no research at all. As the video puts it, EFIC enables research that saves lives, and continued dialogue will keep it honest.
This article is based on the Clarity Clinical Solutions video "Clinical Trial Emergency Settings EFIC: What You Need to Know." Watch it here: Clinical Trial Emergency Settings EFIC: What You Need to Know
References
- Clarity Clinical Solutions — "Clinical Trial Emergency Settings EFIC: What You Need to Know" (framework for this article). https://www.youtube.com/watch?v=l38sALEBMp0
- eCFR — 21 CFR 50.24, the regulation defining exception from informed consent requirements for emergency research. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-50/subpart-B/section-50.24
- FDA — Guidance for IRBs, Clinical Investigators, and Sponsors: Exception from Informed Consent Requirements for Emergency Research. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/exception-informed-consent-requirements-emergency-research